| Similar Articles |
|---|
 |
Information Today
July 2, 2013 |
Thomson Reuters Offers Clinical Trial Intelligence Solutions These solutions improve clinical trials, speed up product development and release, and help professionals strengthen portfolios and R&D strategy.   |
Information Today
October 29, 2015 |
Thomson Reuters Streamlines Healthcare Industry Analysis Thomson Reuters rolled out the Healthcare Intelligence application for Thomson Reuters Eikon to improve workflow for financial professionals. |
Information Today
November 14, 2011
Tara Breton |
New Pharmaceutical Information Tool Coming From Thomson Reuters--Cortellis The content of the system at the moment is limited to competitive intelligence, pipeline information gleaned from sources such as Thomson Reuters Pharma, and patent information from Dolphin. |
Information Today
October 27, 2008 |
Thomson Reuters Launches Integrated Solution Suite With a single login, corporate professionals tasked with researching competitors or prospects, developing growth strategies, or managing financial performance can now access all the information, analytics, and tools they need. |
Information Today
January 7, 2010 |
Thomson Reuters Acquires Discovery Logic, Inc. The acquisition is designed to enhance current research analytics offerings and provide increased decision support and workflow solutions to academic, government, nonprofit, and commercial professionals. |
Bio-IT World
March 10, 2003
Spink & Blumenstiel |
Getting IT Right Applying information technology to trials can boost productivity. Here's a strategic framework for going e-clinical. |
Chemistry World
November 12, 2013
Dinsa Sachan |
Rough patch for India's clinical trial industry The Indian clinical trial industry is beset by uncertainty. Campaigners have petitioned the courts claiming that drug companies are exploiting poor people and this has led to more than 100 trials being put on hold. |
Bio-IT World
August 2005
Ellen H. Julian |
Tech Expertise Singles Out Outsourcers Biopharmaceutical companies are flocking to consultants, outsourcers, and staffing firms to help with discrete clinical trial processes to gain access to advanced technologies and reduce the drain on already-scarce IT resources. |
Bio-IT World
June 2006
Mark D. Uehling |
Afferenz on EDC, Images, and Data Integration There are people who think the outsourcing of IT to India will not affect the life sciences. But companies like Afferenz raises concerns about U.S. companies lagging behind Indian companies on laying the foundation for clinical trials. |
Information Today
April 24, 2008 |
Thomson Innovation Adds Business and News Information This new content joins Thomson Innovation's range of resources for prior art and competitive intelligence research. |
Information Today
December 13, 2010 |
Thomson Reuters Launches Custom Fields in Thomson Innovation IP professionals, innovators, researchers, attorneys, and patent portfolio managers can now create custom fields, allowing them to tag patent records with their own internal data |
Chemistry World
August 7, 2013
Emma Stoye |
AllTrials releases plan for clinical trial reporting The organizations behind AllTrials, a public campaign calling for detailed information on clinical trials to be publically available, have put together a detailed plan on how to achieve clinical trial reporting on a global scale. |
Bio-IT World
March 2006
Salvatore Salamone |
Pfizer Digs Deeper in Mining Trial Data Besides using the information mined from past trials to help design new studies, examine new uses for a drug, or study ways to minimize risks, the data-mining efforts are also being applied to looking at how drugs on the market are being used. |
Chemistry World
January 25, 2013
Rajesh Parishwad |
Indian supreme court's anger over unregulated clinical trials The fledgling clinical trials industry in India has been hit by recent revelations of a lack of regulation. Now, the country's supreme court has criticized the body that oversees clinical trials for its inaction in the face of these unethical practices. |
Bio-IT World
March 10, 2003
Kenneth Getz |
E-Clinical Technology Overview Clinical trial researchers want to leverage the benefits of IT -- and now they can for every core process. But they also have to get past the barriers to adoption. |
Bio-IT World
January 21, 2005 |
How IT Can Decrease Time-to-Market in Clinical Trials Pharma manufacturers can learn from their industrial counterparts: Integrating systems can accelerate product delivery. |
Information Today
June 26, 2014 |
Thomson Reuters and Royal Philips Team Up to Protect IP The partnership is designed to protect intellectual property, business intelligence, and foster product innovation. |
Chemistry World
October 15, 2013
Dinsa Sachan |
Supreme court ruling brings clinical trials to a halt in India The fate of 162 global clinical trials hangs in the balance, as the top Indian court has asked the government to provide more details on their approval process before they can proceed. |
Pharmaceutical Executive
June 9, 2014
Getz et al. |
Adaptive Trial Design: Prepping for Adoption Biopharmaceutical companies are targeting improvements in clinical trial design as a critical factor in pipeline portfolio success. |
Bio-IT World
November 2006
Mark D. Uehling |
Putting EDC on the Fast Track There's no escaping the imposing numbers of choices in launching a clinical trial using electronic data capture. Is there a better way? Clinical trial consultant Fast Track Systems says it has one. |
Information Today
September 26, 2013 |
Thomson Reuters and 4DD Tackle Big Data Government agencies, banks, academic institutions, large law firms, and other Thomson Reuters customers can form patterns using key data and see the complete picture of their research, as well as get real-time information to help them in decision making. |
Pharmaceutical Executive
September 1, 2008
Melanie North |
Publish or Perish FDAAA means that companies need to register clinical trials; and not only for publication planning. |
Information Today
March 8, 2012 |
Latest Version of Thomson Reuters ProView E-Reader Platform Launches Globally Thomson Reuters ProView is a professional-grade platform for the delivery and use of specialized Thomson Reuters content and productivity tools, including popular legal reference books. |
Information Today
March 14, 2011 |
Reuters Powers New Services for Science, Legal, Tax, and Accounting Pros Thomson Reuters is launching a suite of news products designed for the information needs of professionals in the legal, tax and accounting, and science markets. It will combine Reuters news with the content of products like Westlaw and Checkpoint. |
Pharmaceutical Executive
October 1, 2008
RS Kumar |
Evolving Clinical Trials Clinical trials need to change. A recent survey shows that industry should address the research supply chain for the greatest gains in efficiency. |
Information Today
September 3, 2009 |
IFR Intelligence Reports Now Available on Sony Reader Thomson Reuters International Financing Review, an online news and market analysis service, introduced the Sony Reader as a new platform for downloading market intelligence reports. |
Bio-IT World
May 9, 2003
Mark D. Uehling |
Data Rapture? Electronic capture of data: Some say it unclogs the medieval clinical trials process. Others remain skeptical of software and put their trust in paper. |
The Motley Fool
June 8, 2011
Frank Vinluan |
Oxygen Biotherapeutics Expands TBI Trials to India, Seeks Partner The drug development company is now looking for a pharmaceutical partner who could help take its experimental treatment through clinical trials. |
Information Today
November 5, 2013 |
Thomson Reuters and SciELO Join Forces The Intellectual Property & Science business of Thomson Reuters partnered with SciELO (Scientific Electronic Library Online) to integrate the SciELO Citation Index into the Web of Knowledge, Thomson Reuters' search and discovery platform. |
The Motley Fool
December 27, 2006
Brian Lawler |
Telik Falls Short Shares of another biopharma fall after disappointing clinical trial results. |
Information Today
July 9, 2015 |
The BMJ Requires Patient-Level Data for Publication The BMJ is now applying its data-sharing policy to all clinical trials. |
Information Today
December 17, 2013 |
Thomson Reuters Enhances Research and Analytics Tools The Intellectual Property & Science business of Thomson Reuters acquired German-based AVEDAS, which specializes in the development and implementation of current research information systems |
Information Today
February 27, 2014 |
Thomson Reuters Updates SAEGIS Platform Thomson CompuMark, an Intellectual Property & Science business of Thomson Reuters, introduced an update to its SAEGIS platform, adding a new Industrial Designs database. |
Information Today
November 29, 2004
Paula J. Hane |
Thomson Announces New Pharma Research Tool The Thomson Corp. is using the Online Information exhibition in London for the official launch of its new integrated research tool for the pharmaceutical and biotech industries. |
Chemistry World
October 8, 2014
Phillip Broadwith |
EMA finalizes trial transparency rules The European Medicines Agency has finalized its policy for sharing data from clinical trials. |
Bio-IT World
April 16, 2004
Joel Hoffman |
Taking the Trial Out of Clinical Outsourcing Make sure the vendor's standard operating procedures will mesh with your own, and then tirelessly work toward systems integration. |
Information Today
June 20, 2013 |
Thomson Innovation Acquires Full-Text Australian Patent Records Thomson Innovation, the Intellectual Property & Science business of Thomson Reuters, now includes the full text of patents from Australia: innovation (petty) and granted patents and applications. |
The Motley Fool
October 12, 2010
Travis Hoium |
Geron Shares Popped: What You Need to Know Geron shares jumped 10% after the company announced that its first patient has enrolled in the company's stem cell clinical trial. |
AskMen.com
Richard Stevens |
Participating In Clinical Trials Check out what participating in clinical trials involves and how you can join a study. You may even make some cash in the process. |
Bio-IT World
January 13, 2003
Mark D. Uehling |
Powerhouse CRO (Slowly) Goes Electronic Unhappy customers at Quintiles -- the world's largest CRO (contract research organization) -- are rare. It kept plugging away at the startup process, redesigning it from scratch. Now starting electronic trials takes no longer than paper ones. |
Information Today
July 2, 2015 |
Thomson Reuters Rolls Out APIs for Elektron The open source APIs streamline access to Thomson Reuters' data feeds and services. |
Information Today
August 20, 2013 |
Thomson Reuters Elite Releases Business Development Premier It uses customer relationship management and enterprise relationship management tools to analyze company and competitive intelligence data. |
Chemistry World
September 11, 2014
Emma Stoye |
Pharma sales 'will reach $1 trillion' in 2014 Global sales in the pharmaceutical industry are set to go over the $1 trillion mark this year, according to a report by Thomson Reuters. |
The Motley Fool
September 8, 2004
Charly Travers |
Will a Clinical Trial Database Help Investors? While this development is certainly good news for patients and physicians, the impact on investors may be minimal, depending upon the type of data that will be released. |
Information Today
August 3, 2009 |
Thomson Reuters Introduces New IP Offering for Law Firms This new offering pairs the authoritative legal content of Westlaw with the rich patent research capabilities of Thomson Innovation. It is designed to help legal professionals work smarter and more efficiently across the patent workflow-from patent prosecution to litigation. |
The Motley Fool
May 9, 2007
Mike Havrilla |
Scintillating Synta Patient investors should peek at this pharma's promising pipeline. |
Pharmaceutical Executive
November 1, 2006 |
Unraveling the eSource Industry-wide standards for electronic patient data have long felt like buried treasure. Companies today are getting closer - by way of a tangled map. |
Pharmaceutical Executive
October 1, 2005
Lisa Grimes |
Clear Road Ahead An industry standard for publicizing clinical-trial results is a ways off. But pharma's openness to more transparent procedures is moving things in the right direction. |
The Motley Fool
December 8, 2004
Alyce Lomax |
Eli Lilly Bares All The pharmaceutical publishes clinical trial results online. This is a step toward generating trust -- after all, shareholders, physicians, and consumers alike are likely looking askew at Big Pharma these days. |
Chemistry World
March 4, 2013
Andy Extance |
UK considers patent rule change for trials The UK has announced plans to amend aspects of its patent law that may be encouraging pharma companies to run their clinical trials in other countries. |
